Ark's gene therapy stumbles at the finish line.
Mitchell
Peter
P
D002986:Clinical Trials as Topic; D004345:Drug Industry; D015316:Genetic Therapy / Q000379:methods*; D005909:Glioblastoma / Q000235:genetics / Q000628:therapy; D006801:Humans; D013937:Thymidine Kinase / Q000592:standards / Q000627:therapeutic use*
D013937:Thymidine Kinase; C529697:sitimagene ceradenovec